INTEGRA LIFESCIENCES HOLDINGS CORP OCI, before Reclassifications, Net of Tax, Attributable to Parent
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported OCI, before Reclassifications, Net of Tax, Attributable to Parent of $17.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2026-06-30 was $5.05M.
- INTEGRA LIFESCIENCES HOLDINGS CORP oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2026-03-31 was $12.48M.
- INTEGRA LIFESCIENCES HOLDINGS CORP oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-12-31 was -$1.49M, a 105.56% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-09-30 was $9.69M.
- INTEGRA LIFESCIENCES HOLDINGS CORP oci, before reclassifications, net of tax, attributable to parent for fiscal 2025 was -$29.13M, a 170.97% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP oci, before reclassifications, net of tax, attributable to parent for fiscal 2024 was $41.04M.
- INTEGRA LIFESCIENCES HOLDINGS CORP oci, before reclassifications, net of tax, attributable to parent for fiscal 2023 was -$29.50M, a 142.17% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP oci, before reclassifications, net of tax, attributable to parent for fiscal 2022 was $69.96M, a 66.58% increase from fiscal 2021.
| Period end | OCI, before Reclassifications, Net of Tax, Attributable to Parent 3 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 6 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 9 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $17.53M 10-Q · filed 2026-07-29 | $16.04M derived: sum of 3 quarters · filed 2026-07-29 | $25.73M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $12.48M 10-Q · filed 2026-05-05 | $10.99M derived: sum of 2 quarters · filed 2026-05-05 | $20.69M derived: sum of 3 quarters · filed 2026-05-05 | -$16.20M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.20M derived: sum of 2 quarters · filed 2026-02-26 | -$28.68M derived: sum of 3 quarters · filed 2026-02-26 | -$29.13M 10-K · filed 2026-02-26 |
| 2025-09-30 | $9.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$27.19M derived: sum of 2 quarters · filed 2025-10-30 | -$27.64M 10-Q · filed 2025-10-30 | -$887.00K derived: sum of 4 quarters · filed 2025-10-30 |
| 2025-06-30 | -$36.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$37.33M 10-Q · filed 2025-07-31 | -$10.58M derived: sum of 3 quarters · filed 2025-07-31 | -$31.04M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | -$446.00K 10-Q · filed 2025-05-05 | $26.30M derived: sum of 2 quarters · filed 2025-05-05 | $5.85M derived: sum of 3 quarters · filed 2025-05-05 | $3.23M derived: sum of 4 quarters · filed 2025-05-05 |
| 2024-12-31 | $26.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $6.29M derived: sum of 2 quarters · filed 2025-02-25 | $3.68M derived: sum of 3 quarters · filed 2025-02-25 | $41.04M 10-K · filed 2025-02-25 |
| 2024-09-30 | -$20.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$23.07M derived: sum of 2 quarters · filed 2024-11-04 | $14.29M 10-Q · filed 2024-11-04 | -$24.18M derived: sum of 4 quarters · filed 2024-11-04 |
| 2024-06-30 | -$2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $34.74M 10-Q · filed 2024-07-29 | -$3.73M derived: sum of 3 quarters · filed 2024-07-29 | $10.26M derived: sum of 4 quarters · filed 2024-07-29 |
| 2024-03-31 | $37.36M 10-Q · filed 2024-05-06 | -$1.11M derived: sum of 2 quarters · filed 2024-05-06 | $12.88M derived: sum of 3 quarters · filed 2024-05-06 | $9.43M derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-12-31 | -$38.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$24.48M derived: sum of 2 quarters · filed 2024-02-28 | -$27.93M derived: sum of 3 quarters · filed 2024-02-28 | -$29.50M 10-K · filed 2024-02-28 |
| 2023-09-30 | $13.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $10.54M derived: sum of 2 quarters · filed 2023-10-25 | $8.97M 10-Q · filed 2023-10-25 | $8.87M derived: sum of 4 quarters · filed 2023-10-25 |
| 2023-06-30 | -$3.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | -$5.02M 10-Q · filed 2023-07-27 | -$5.12M derived: sum of 3 quarters · filed 2023-07-27 | $16.24M derived: sum of 4 quarters · filed 2023-07-27 |
| 2023-03-31 | -$1.57M 10-Q · filed 2023-04-26 | -$1.68M derived: sum of 2 quarters · filed 2023-04-26 | $19.69M derived: sum of 3 quarters · filed 2023-04-26 | $40.84M derived: sum of 4 quarters · filed 2023-04-26 |
| 2022-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $21.26M derived: sum of 2 quarters · filed 2023-02-22 | $42.41M derived: sum of 3 quarters · filed 2023-02-22 | $69.96M 10-K · filed 2023-02-22 |
| 2022-09-30 | $21.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $42.52M derived: sum of 2 quarters · filed 2022-10-26 | $70.06M 10-Q · filed 2022-10-26 | $64.35M derived: sum of 4 quarters · filed 2022-10-26 |
| 2022-06-30 | $21.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $48.70M 10-Q · filed 2022-07-27 | $42.98M derived: sum of 3 quarters · filed 2022-07-27 | $47.82M derived: sum of 4 quarters · filed 2022-07-27 |
| 2022-03-31 | $27.54M 10-Q · filed 2022-04-27 | $21.83M derived: sum of 2 quarters · filed 2022-04-27 | $26.67M derived: sum of 3 quarters · filed 2022-04-27 | $8.24M derived: sum of 4 quarters · filed 2022-04-27 |
| 2021-12-31 | -$5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$875.00K derived: sum of 2 quarters · filed 2022-02-24 | -$19.30M derived: sum of 3 quarters · filed 2022-02-24 | $41.99M 10-K · filed 2022-02-24 |
| 2021-09-30 | $4.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$13.59M derived: sum of 2 quarters · filed 2021-11-02 | $47.71M 10-Q · filed 2021-11-02 | $55.41M derived: sum of 4 quarters · filed 2021-11-02 |
| 2021-06-30 | -$18.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $42.87M 10-Q · filed 2021-07-29 | $50.57M derived: sum of 3 quarters · filed 2021-07-29 | $54.99M derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | $61.29M 10-Q · filed 2021-04-29 | $68.99M derived: sum of 2 quarters · filed 2021-04-29 | $73.41M derived: sum of 3 quarters · filed 2021-04-29 | $72.32M derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $12.12M derived: sum of 2 quarters · filed 2021-02-23 | $11.03M derived: sum of 3 quarters · filed 2021-02-23 | -$16.43M 10-K · filed 2021-02-23 |
| 2020-09-30 | $4.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $3.33M derived: sum of 2 quarters · filed 2020-10-29 | -$24.13M 10-Q · filed 2020-10-29 | -$15.96M derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$28.54M 10-Q · filed 2020-08-10 | -$20.38M derived: sum of 3 quarters · filed 2020-08-10 | -$31.82M derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | -$27.46M 10-Q · filed 2020-05-07 | -$19.30M derived: sum of 2 quarters · filed 2020-05-07 | -$30.73M derived: sum of 3 quarters · filed 2020-05-07 | -$42.54M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | $8.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$3.27M derived: sum of 2 quarters · filed 2020-02-21 | -$15.08M derived: sum of 3 quarters · filed 2020-02-21 | -$19.57M 10-K · filed 2020-02-21 |
| 2019-09-30 | -$11.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | -$23.24M derived: sum of 2 quarters · filed 2019-10-25 | -$27.73M 10-Q · filed 2019-10-25 | -$42.90M derived: sum of 4 quarters · filed 2019-10-25 |
| 2019-06-30 | -$11.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$16.29M 10-Q · filed 2019-07-25 | -$31.47M derived: sum of 3 quarters · filed 2019-07-25 | -$32.65M derived: sum of 4 quarters · filed 2019-07-25 |
| 2019-03-31 | -$4.48M 10-Q · filed 2019-04-29 | -$19.66M derived: sum of 2 quarters · filed 2019-04-29 | -$20.84M derived: sum of 3 quarters · filed 2019-04-29 | -$33.08M derived: sum of 4 quarters · filed 2019-04-29 |
| 2018-12-31 | -$15.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$16.35M derived: sum of 2 quarters · filed 2019-02-26 | -$28.60M derived: sum of 3 quarters · filed 2019-02-26 | -$10.87M 10-K · filed 2019-02-26 |
| 2018-09-30 | -$1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$13.42M derived: sum of 2 quarters · filed 2018-11-01 | $4.31M 10-Q · filed 2018-11-01 | $6.17M derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | -$12.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $5.49M 10-Q · filed 2018-07-26 | $7.35M derived: sum of 3 quarters · filed 2018-07-26 | $17.79M derived: sum of 4 quarters · filed 2018-07-26 |
| 2018-03-31 | $17.73M 10-Q · filed 2018-04-26 | $19.59M derived: sum of 2 quarters · filed 2018-04-26 | $30.03M derived: sum of 3 quarters · filed 2018-04-26 | |
| 2017-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $12.30M derived: sum of 2 quarters · filed 2018-03-01 | $32.26M 10-K · filed 2018-03-01 | |
| 2017-09-30 | $10.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $30.39M 10-Q · filed 2017-10-26 | ||
| 2017-06-30 | $19.95M 10-Q · filed 2017-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |